Home Applications 022345 Application 022345
Type NDA
Sponsor GLAXOSMITHKLINE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 POTIGA EZOGABINE TABLET;ORAL 50MG Yes No 002 POTIGA EZOGABINE TABLET;ORAL 200MG Yes No 003 POTIGA EZOGABINE TABLET;ORAL 300MG Yes No 004 POTIGA EZOGABINE TABLET;ORAL 400MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022345-001 POTIGA EZOGABINE 50MG TABLET / ORAL RLD 2011-06-10 N022345-002 POTIGA EZOGABINE 200MG TABLET / ORAL RLD 2011-06-10 N022345-003 POTIGA EZOGABINE 300MG TABLET / ORAL RLD 2011-06-10 N022345-004 POTIGA EZOGABINE 400MG TABLET / ORAL RLD 2011-06-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 5 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 e64feba35796…2022-09-29 23:25 UTC 2022-09 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 e64feba35796…2022-09-29 23:25 UTC 2022-09 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 e64feba35796…2022-09-29 23:25 UTC 2022-09 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022345-001 POTIGA 50MG TABLET / ORAL RLD 2011-06-10 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022345-002 POTIGA 200MG TABLET / ORAL RLD 2011-06-10 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022345-003 POTIGA 300MG TABLET / ORAL RLD 2011-06-10 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N022345-004 POTIGA 400MG TABLET / ORAL RLD 2011-06-10 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0173-0810 POTIGA ezogabine GlaxoSmithKline LLC NDA Current 0173-0812 POTIGA ezogabine GlaxoSmithKline LLC NDA Current 0173-0814 POTIGA ezogabine GlaxoSmithKline LLC NDA Current